MSD announces the Primary Results of Trial uating Cardiovascular Outcomes with Sitagliptin
MSD, known as Merck in the United States and Canada, has announced the primary results of the Trial uating Cardiovascular […]
Tags: American Diabetes Association, Anti-diabetic medication, Canada, Cardiovascular disease, diabetes, Diabetic Medicine and Diabetes Trials Unit, Dipeptidyl peptidase-4 inhibitors, Director, Duke Clinical Research Institute, Health/Medical/Pharmaceuticals, Heart Failure, II diabetes, JANUVIA, medicine, Merck & Co, Merck Research Laboratories, New England Journal, nonfatal myocardial infarction, nonfatal stroke, Organofluorides, Pharmaceutical industry, Pharmacology, President, professor, Roger M. Perlmutter, Rury Holman, Sitagliptin, study co-chair, the New England Journal of Medicine, United States, University of Oxford, unstable angina
Price Monitoring Cell by Karnataka Drugs Control Department
The Karnataka drugs control department has set up price monitoring cell following the directive from the National Pharmaceutical Pricing Authority […]
Pharma Industry to Create 45000 more Jobs in 2015
With the growing market in the pharma sector, has opened the doors to job opportunities. In this year itself […]
Mankind Pharma Moves on ‘Make in India’ Path
Mankind Pharma is all set to launch the API factory by this year to promote affordable drug manufacturing in India. […]
Natco ties up with Gilead Sciences for Hepatitis C drug
Nacto Pharma has received voluntary licence to manufacture the generic versions of US drug maker Gilead Sciences’ hepatitis C drug […]
Sun Pharma acquires GSK’s opiates business in Australia
Sun Pharmaceutical Industries has acquired multinational drug maker GlaxoSmithKline’s opiates business in Australia. However, the deals of the deal have […]
Natco Pharma ties up with Gilead
According to a press release Natco Pharma Limited has signed a licensing deal with Gilead Sciences Inc to make and […]
Finance Minister Arun Jaitley allocated Rs 33,150 crore for the Healthcare Sector
Finance Minister Arun Jaitley allocated Rs 33,150 crore for the healthcare sector today. The government also raised the health insurance […]
ISCR Ponders Over Bringing Achche Din in Clinical Research
Padma Shri Prof Ranjit Roy Chaudhury in his keynote address at the inauguration of the 8th Annual Clinical Research Conference […]
8th ISCR Annual Conference to discuss Clinical Research in India – 13 &14th February, 2015
Clinical Research in India “ Towards Achche Din will be the theme of the 8th Annual Conference of the Indian […]
India’s Pharma Exports to Reach Rs 1.1 Lakh Crore by FY16: Ind-Ra
India’s pharma exports are expected to reach Rs 1,10,000 crore by year 2015-16 from Rs 91,000 crore last fiscal, says […]
JP Nadda: Regulatory Pathway for Pharma Companies
The Union Minister of Health and Family Welfare have proposed a regulatory pathway for pharmaceutical companies conducting clinical trials and […]
Drugs and Cosmetics Bill, 2015
The Ministry of Health and Family Welfare has invited feedback on the draft Drugs and Cosmetics Bill. The Centre would […]
